| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $933,174 | 5 | 71 |
Sells | $132,328 | 2 | 29 |
| Pangalos Menelas N | director | 2 | $406,508 | 0 | $0 | $406,508 |
| Busch Andreas | Chief Innovation Officer | 1 | $229,000 | 0 | $0 | $229,000 |
| Szela Mary T | director | 1 | $148,866 | 0 | $0 | $148,866 |
| VAN HOUTEN FRANS | director | 1 | $148,800 | 0 | $0 | $148,800 |
| Jonasson Zachariah | CFO / CBO | 0 | $0 | 1 | $52,313 | $-52,313 |
| McClain Sean | Chief Executive Officer | 0 | $0 | 1 | $80,015 | $-80,015 |
Absci Corporation operates as a biopharmaceutical company primarily focused on discovering novel drug targets and developing new therapeutic compounds. Leveraging its distinctive integrated drug creation platform, the firm generates potential biologic medicines and essential cell lines for manufacturing, which it provides to its collaborators, predominantly within the United States. This advanced platform is instrumental in facilitating the development of biologics by meticulously integrating the traditionally separate stages of drug discovery …
Over the last 12 months, insiders at Absci Corporation have bought $933,174 and sold $132,328 worth of Absci Corporation stock.
On average, over the past 5 years, insiders at Absci Corporation have bought $616,326 and sold $6.94M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Pangalos Menelas N (director) — $406,508. Busch Andreas (Chief Innovation Officer) — $229,000. Szela Mary T (director) — $148,866.
The last purchase of 12,900 shares for transaction amount of $148,866 was made by Szela Mary T (director) on 2026‑06‑30.
| 2026-06-30 | Szela Mary T | director | 12,900 0.0076% | $11.54 | $148,866 | -20.36% | ||
| 2026-05-13 | Pangalos Menelas N | director | 37,453 0.024% | $5.36 | $200,748 | +67.83% | ||
| 2026-03-12 | Busch Andreas | Chief Innovation Officer | 100,000 0.0662% | $2.29 | $229,000 | +256.96% | ||
| 2026-02-27 | Pangalos Menelas N | director | 75,095 0.0499% | $2.74 | $205,760 | +191.61% | ||
| 2026-02-02 | Sale | McClain Sean | Chief Executive Officer | 26,761 0.0176% | $2.99 | $80,015 | +141.89% | |
| 2026-02-02 | Sale | Jonasson Zachariah | CFO / CBO | 17,496 0.0115% | $2.99 | $52,313 | +141.89% | |
| 2025-12-05 | VAN HOUTEN FRANS | director | 40,000 0.0276% | $3.72 | $148,800 | +61.03% | ||
| 2025-09-22 | Bedrick Todd | SVP, CAO | 10,000 0.0067% | $2.70 | $27,000 | +44.98% | ||
| 2025-09-22 | Pangalos Menelas N | director | 95,785 0.0633% | $2.66 | $254,788 | +44.98% | ||
| 2025-07-28 | Busch Andreas | Chief Innovation Officer | 50,000 0.0401% | $3.04 | $152,000 | +12.46% | ||
| 2024-06-13 | Sale | Jonasson Zachariah | CFO / CBO | 19,859 0.0194% | $4.98 | $98,892 | -21.85% | |
| 2024-05-22 | Sale | Phoenix Venture Partners II LP | 10 percent owner | 3.1M 2.6164% | $4.40 | $13.64M | -19.85% | |
| 2024-03-01 | Redmile Group, LLC | director | 222,222 0.1982% | $4.50 | $999,999 | -24.91% | ||
| 2022-02-09 | Korman Sarah | General Counsel | 4,250 0.0044% | $7.96 | $33,830 | -59.91% | ||
| 2022-01-20 | Bedrick Todd | VP, CCPAO | 2,000 0.0023% | $7.50 | $15,000 | -50.42% | ||
| 2022-01-19 | McClain Sean | President and Chief Executive | 7,155 0.0081% | $6.92 | $49,513 | -47.79% | ||
| 2021-07-26 | Redmile Group, LLC | director | 1.88M 1.7426% | $16.00 | $30M | -63.43% | ||
| 2021-07-26 | Casdin Partners Master Fund, L.P. | director | 1.56M 1.4521% | $16.00 | $25M | -63.43% | ||
| 2021-07-26 | Casdin Eli | director | 1.56M 1.4521% | $16.00 | $25M | -63.43% | ||
| 2021-07-26 | McClain Sean | President and Chief Executive | 600 0.0006% | $16.00 | $9,600 | -63.43% |
| McClain Sean | Chief Executive Officer | 8334567 4.8566% | $83.35M | 2 | 1 | <0.0001% |
| Busch Andreas | Chief Innovation Officer | 421446 0.2456% | $4.21M | 2 | 0 | +12.46% |
| Jonasson Zachariah | CFO / CBO | 383538 0.2235% | $3.84M | 1 | 2 | <0.0001% |
| Pangalos Menelas N | director | 232308 0.1354% | $2.32M | 3 | 0 | +44.98% |
| VAN HOUTEN FRANS | director | 63320 0.0369% | $633,200.00 | 1 | 0 | |
| Szela Mary T | director | 21300 0.0124% | $213,000.00 | 1 | 0 | |
| Redmile Group, LLC | director | 8253316 4.8092% | $82.53M | 2 | 0 | <0.0001% |
| Casdin Eli | director | 6745333 3.9305% | $67.45M | 1 | 0 | <0.0001% |
| Casdin Partners Master Fund, L.P. | director | 6745333 3.9305% | $67.45M | 1 | 0 | <0.0001% |
| Bedrick Todd | SVP, CAO | 180428 0.1051% | $1.8M | 3 | 0 | <0.0001% |
| MCGINNIS KAREN K | director | 15000 0.0087% | $150,000.00 | 1 | 0 | <0.0001% |
| Korman Sarah | General Counsel | 14250 0.0083% | $142,500.00 | 2 | 0 | <0.0001% |
$8,217,280 | 112 | 46.33% | $1.6B | |
$607,395,062 | 99 | 4.23% | $1.88B | |
$54,660,406 | 66 | 22.24% | $1.5B | |
$47,419,530 | 58 | 17.20% | $1.96B | |
$61,893,001 | 38 | 19.63% | $1.89B |
| Increased Positions | 73 | +51.77% | 28M | +28.9% |
| Decreased Positions | 51 | -36.17% | 5M | -4.9% |
| New Positions | 23 | New | 12M | New |
| Sold Out Positions | 19 | Sold Out | 1M | Sold Out |
| Total Postitions | 163 | +15.6% | 120M | +24% |
| Fmr Llc | $79,721.00 | 14.72% | 22.08M | +3M | +15.42% | 2025-09-30 |
| Ark Investment Management Llc | $43,908.00 | 8.11% | 12.16M | +2M | +21.07% | 2025-09-30 |
| Blackrock, Inc. | $38,205.00 | 7.06% | 10.58M | +2M | +26.58% | 2025-09-30 |
| Redmile Group, Llc | $29,794.00 | 5.5% | 8.25M | 0 | 0% | 2025-09-30 |
| Vanguard Group Inc | $26,288.00 | 4.86% | 7.28M | +830,336 | +12.87% | 2025-09-30 |
| Ameriprise Financial Inc | $11,520.00 | 2.13% | 3.19M | +625,451 | +24.38% | 2025-09-30 |
| Geode Capital Management, Llc | $11,021.00 | 2.04% | 3.05M | +607,465 | +24.84% | 2025-09-30 |
| Massachusetts Financial Services Co /Ma/ | $7,972.00 | 1.47% | 2.21M | -18,778 | -0.84% | 2025-09-30 |
| State Street Corp | $7,454.00 | 1.38% | 2.06M | +261,876 | +14.52% | 2025-09-30 |
| Heights Capital Management, Inc | $7,222.00 | 1.33% | 2M | +2M | New | 2025-09-30 |